CERAMIND, powered by Cerebroprotein Hydrolysate 90 mg, is a scientifically advanced neurotrophic agent designed for the management of neurodegenerative and neurovascular disorders. Extracted from porcine brain tissue, it mimics human neuropeptides, allowing rapid penetration into the CNS and exerting a range of neuroprotective and neurorestorative effects.
CERAMIND plays a pivotal role in improving cognitive function, memory, attention, and vigilance. It is clinically used for conditions like acute ischemic stroke, traumatic brain injury, vascular dementia, and Alzheimer’s disease. By modulating synaptic plasticity and neuronal metabolism, CERAMIND accelerates brain repair and enhances nerve growth.
What sets CERAMIND apart from other neuroprotective agents is its multi-mechanistic action. It regulates excitotoxicity, inhibits calcium-dependent proteases, and scavenges free radicals—three key factors contributing to neurodegeneration. It also promotes neuronal differentiation and shields against ischemic and toxic damage.
Clinically, CERAMIND has demonstrated faster onset of action and better outcomes in stroke recovery and dementia management. It is a safe, effective, and well-tolerated option that addresses the growing burden of neurodegenerative diseases in both aging and younger populations.
? Bullet Points:
Faster recovery in brain injuries